Prosecution Insights
Last updated: August 06, 2026

Pleechae Intellectual Property LLC

19 pending office actions • 11 clients • 19 examiners • 15 art units • 0 of 19 (0%) have an AI response strategy ready

Quality Metrics (n=99 apps, methodology: how we score firms)

79.3%
Allowance Rate
n=99
+0.46σ
Allowance Rate (norm)
n=99
1.9
OAs to Allowance
n=23
-0.91σ
OAs to Allow (norm)
n=23
800 days
Time to Allowance
n=23
+26.1pp
Interview Lift
n=99
17.2%
RCE Rate
n=99
0.0%
Appeal Rate
n=99

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=4 (min 20)
28.0%
§102 Overcome
n=25
26.7%
§103 Overcome
n=30
35.0%
§112 Overcome
n=20

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
35%
Top-3 CPC Share
n=99
0
Practitioners
n=99
Apps / Practitioner
n=99 (min 20)

Portfolio Summary

19
Total Pending OAs
13
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (37%)
10
Medium (53%)
2
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (32%)
§102 only3 (16%)
§112 only1 (5%)
Double-patenting only1 (5%)
Double-patenting + other1 (5%)
Multi-statute (no §101)7 (37%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
74% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
1
Mechanical / Eng
5% of docket
3
Business / Other
16% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CATTUNGAL, SANJAY 1 83.3% +11.3%
STOYTCHEV, MARIN STOYTCHEV 1 75.0% +27.9%
GU, QINHUA 1 77.3% +27.6%
SHI, GENBIN 1
LEON MUNOZ, EDWIN A 1 88.4% +8.1%
ALLEY, GENEVIEVE S 1 60.4% +48.3%
BASQUILL, SEAN M 1 38.8% +21.7%
TOWNSLEY, SARA ELIZABETH 1 25.1% +48.8%
CHANG, KYUNG SOOK 1 60.5% +41.0%
TICHY, JENNIFER M.H. 1 65.0% +34.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18282298 APPARATUS, METHOD AND SYSTEM FOR PROVIDING TACTILE MEDIUM CATTUNGAL, SANJAY

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17845493 POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME KAHN, RACHEL 1d overdue
18711270 METHOD FOR CONSTRUCTION OF INNER EAR ORGANOID GU, QINHUA
18700884 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE COMPRISING LYSOPHOSPHOLIPID SHI, GENBIN
18700388 RF CONNECTOR HAVING SHIELDING STRUCTURE LEON MUNOZ, EDWIN A
18692447 PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF OSTEOARTHRITIS BASQUILL, SEAN M
18690418 COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS TOWNSLEY, SARA ELIZABETH
18279965 METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR-MACROPHAGES AND USE OF SAME CELLS OUSPENSKI, ILIA I
18278468 MAGNET ASSEMBLY FOR MOBILE TERMINAL AND WIRELESS CHARGING DEVICE COMBINED THEREWITH TAYLOR, APRIL ALICIA

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18681600 COMPOSITION FOR GENERATING NITROGEN MONOXIDE CHANG, KYUNG SOOK 9d
18282298 APPARATUS, METHOD AND SYSTEM FOR PROVIDING TACTILE MEDIUM CATTUNGAL, SANJAY
18720849 SMART CONTACT LENS STOYTCHEV, MARIN STOYTCHEV
18711270 METHOD FOR CONSTRUCTION OF INNER EAR ORGANOID GU, QINHUA
18696589 PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES ALLEY, GENEVIEVE S
18692447 PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF OSTEOARTHRITIS BASQUILL, SEAN M
18690418 COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS TOWNSLEY, SARA ELIZABETH
18577427 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VASCULAR DEMENTIA TICHY, JENNIFER M.H.

Client Portfolio (11 clients)

Top Art Units

Art UnitApps
16172
37981
28721
16281
16141
16291
16131
16531
16311
16121

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18282298 APPARATUS, METHOD AND SYSTEM FOR PROVIDING TACTILE MEDIUM Seoul National University R&Db Foundation CATTUNGAL, SANJAY 3798 §102Other Non-Final OA Pending Dec 13, 2024
18720849 SMART CONTACT LENS Opthroth Inc. STOYTCHEV, MARIN STOYTCHEV 2872 §112 Non-Final OA Pending Jun 17, 2024
18711270 METHOD FOR CONSTRUCTION OF INNER EAR ORGANOID Ajou University Industry-Academic Cooperation Foundation GU, QINHUA §102§103§112 Non-Final OA Pending May 17, 2024
18700884 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE COMPRISING LYSOPHOSPHOLIPID Seoul National University R&Db Foundation SHI, GENBIN 1628 §102§103 Non-Final OA Pending Apr 12, 2024
18700388 RF CONNECTOR HAVING SHIELDING STRUCTURE Novatech Co., Ltd. LEON MUNOZ, EDWIN A §102§103 Non-Final OA Pending Apr 11, 2024
18696589 PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES Industry Foundation Of Chonnam National University ALLEY, GENEVIEVE S 1617 §103DP Non-Final OA Pending Mar 28, 2024
18692447 PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF OSTEOARTHRITIS Seoul National University R&Db Foundation BASQUILL, SEAN M 1614 §102§103 Non-Final OA Pending Mar 15, 2024
18690418 COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS Neuroventi Inc. TOWNSLEY, SARA ELIZABETH 1629 §102 Non-Final OA Pending Mar 08, 2024
18681600 COMPOSITION FOR GENERATING NITROGEN MONOXIDE Seoul National University R&Db Foundation CHANG, KYUNG SOOK 1613 §103 Final Rejection 9d Pending Feb 06, 2024
18577427 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VASCULAR DEMENTIA Industry-University Cooperation Foundation Hanyang University TICHY, JENNIFER M.H. 1653 DP Non-Final OA Pending Jan 08, 2024
18577404 MICELLE COMPLEX AND DRUG CARRIER COMPRISING SAME Dr. Cure Co., Ltd. FAY, ZOHREH ALEMZADEH 1617 §103 Non-Final OA 62d Pending Jan 08, 2024
18287435 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PARKINSON'S DISEASE, AND PREPARATION METHOD THEREOF Industry Foundation Of Chonnam National University SCHUBERG, LAURA J 1631 §102 Final Rejection Pending Oct 18, 2023
18375599 COMPOSITION FOR ENHANCING GROWTH OF PLANTS Industry Foundation Of Chonnam National University WELLES, COLMAN THOMAS 1612 §103 Non-Final OA 21d Pending Oct 02, 2023
18284239 COMPOSITION FOR ENHANCING PHYSIOLOGICAL EFFICACY OF LACTIC ACID BACTERIA Seoul National University R&Db Foundation LANKFORD JR, LEON B 1657 §103 Final Rejection 39d Pending Sep 26, 2023
18279965 METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR-MACROPHAGES AND USE OF SAME CELLS Knu-Industry Cooperation Foundation OUSPENSKI, ILIA I 1644 §102§103§112 Non-Final OA Pending Sep 01, 2023
18278468 MAGNET ASSEMBLY FOR MOBILE TERMINAL AND WIRELESS CHARGING DEVICE COMBINED THEREWITH Novatech Co., Ltd. TAYLOR, APRIL ALICIA §102§103§112 Non-Final OA Pending Aug 23, 2023
18024819 PEPTIDE, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Seoul National University Hospital CHANDRA, GYAN 1674 §103 Final Rejection Pending Mar 06, 2023
18018618 ANTIVIRAL COMPOSITION AGAINST CORONAVIRUS Novelgen Co., Ltd. BARRERA, IMMACULADA 1671 §103 Final Rejection 25d overdue Pending Jan 30, 2023
17845493 POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME Jeonju University Office Of Industry-University Cooperation KAHN, RACHEL 1766 §103§112 Final Rejection 1d overdue Pending Jun 21, 2022

Managing Pleechae Intellectual Property LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month